Global success for Presagen and Life Whisperer
03 December 2020
Baby Ebenezer is a happy, healthy 8-week-old – and an IVF success story of a new kind. His entry into the world was aided by artificial intelligence (AI) applied to medical imaging.
He is the first baby to be born as a result of the technology developed by Lot Fourteen based AI healthcare company Presagen, which is made available under the Life Whisperer brand name.
As an embryo, Ebenezer was identified within his cohort to be the one most likely to result in a clinical pregnancy, and thus was the first embryo transferred to his mother’s uterus.
For his parents and their leading Australian IVF clinic, No. 1 Fertility in Melbourne – the first clinic in the world to offer the recently approved technology, this decision resulted in a joyful end to their two-year journey.
Presagen Chief Executive Dr Michelle Perugini said that while medical advances had significantly improved IVF outcomes, they had added to the already substantial, and often prohibitive, cost of treatment.
“What is remarkable about Life Whisperer is that it is non-invasive, affordable, and requires no additional hardware,” she said.
“As such, it can be universally implemented to offer new hope to the millions of would-be parents globally.
“We are so overwhelmed with joy to see our world-first Life Whisperer baby born, and the wonderful impact it has had in helping this couple start a family.”
Using the Life Whisperer embryo assessment program, the embryologist uploads a single image of each 5-day-old embryo in the cycle cohort and within minutes receives a score for each one based on its implantation potential. International clinical studies have shown Life Whisperer is 25% more accurate in assessing embryo viability than assessment by embryologist alone and can reduce the time to pregnancy by 15%.
Life Whisperer is the first product released by Presagen, which has a mission to improve women’s health outcomes globally. It also has bases in San Francisco and London.
Presagen Chief Scientist Dr Jonathan Hall said, “After years of development and testing this technology with IVF clinics globally, it is great to finally see the positive outcomes that AI can have on people’s lives and their health.”
Life Whisperer’s advanced AI program was trained globally on tens of thousands of embryo images matched with pregnancy outcomes. The AI recognizes unknown features and complex patterns, the impacts of which on embryo viability are yet to be fully understood.
Life Whisperer is authorised for use in two-thirds of the world’s IVF market, with IVF clinics globally now using it to help their patients conceive.
Read more: lifewhisperer.com/